₹952.05
▲ +6.62 +0.70%
As of 29 Jul 2026 · delayed
NSE Listed · Healthcare
Fortis Healthcare Ltd. (FORTIS)
Volume: 9,86,990Avg Vol 1W: 8,67,538Avg Vol 1M: 11,41,62652W Range:₹766.8₹1,104.3
Key Ratios
Checked just nowMarket Cap₹71,876 Cr
Current Price₹952.05
Previous Close₹945.43
High / Low (52w)₹1,104.3 / ₹766.8
Volume9,86,990
Avg Vol (1W)8,67,538
Avg Vol (1M)11,41,626
Stock P/E270.47
Book Value₹131.07
Dividend Yield0.1%
ROE10.53%
ROA6.67%
Revenue (TTM)—
Revenue Growth12.91%
Profit Margin11.41%
Total Debt₹2,086 Cr
Shares Outstanding75 Cr
Face Value₹10
EPS (TTM)₹3.52
P/B7.26
Debt / Equity0.35
50 DMA₹961.64
200 DMA₹927.17
Day change+0.70%
Price Chart
₹952.05▲ 11.93% · 1Y
2025-07-292026-07-29
20-day avg volume: 11.0L shares
Pros
- Company is almost debt-free.
- Revenue grew 1892% YoY.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 270.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,859 Cr | ₹1,988 Cr | ₹1,928 Cr | ₹2,007 Cr | ₹2,167 Cr | ₹2,331 Cr | ₹2,265 Cr | ₹2,365 Cr |
| EBITDA | ₹265 Cr | ₹353 Cr | ₹299 Cr | ₹353 Cr | ₹405 Cr | ₹473 Cr | ₹394 Cr | ₹415 Cr |
| Net Profit | ₹166 Cr | ₹176 Cr | ₹248 Cr | ₹184 Cr | ₹260 Cr | ₹322 Cr | ₹194 Cr | ₹266 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹367 Cr | ₹7,850 Cr | ₹388 Cr | ₹433 Cr | ₹456 Cr | ₹443 Cr | ₹9,179 Cr | ₹461 Cr |
| EBITDA | ₹72 Cr | ₹1,269 Cr | ₹65 Cr | ₹98 Cr | ₹164 Cr | ₹85 Cr | ₹1,686 Cr | ₹97 Cr |
| Net Profit | ₹40 Cr | ₹774 Cr | ₹-42 Cr | ₹52 Cr | ₹125 Cr | ₹28 Cr | ₹1,042 Cr | ₹25 Cr |
| EPS | — | 10.26 | — | — | — | — | 13.8 | — |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹11,951 Cr | ₹11,348 Cr | ₹11,155 Cr | ₹11,885 Cr | ₹12,434 Cr | ₹13,289 Cr | ₹13,692 Cr | ₹15,966 Cr |
| Total Liabilities | ₹4,839 Cr | ₹4,142 Cr | ₹4,437 Cr | ₹4,876 Cr | ₹4,333 Cr | ₹4,733 Cr | ₹4,522 Cr | ₹5,798 Cr |
| Equity | ₹7,112 Cr | ₹7,206 Cr | ₹6,718 Cr | ₹7,008 Cr | ₹8,100 Cr | ₹8,556 Cr | ₹9,169 Cr | ₹10,169 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹69 Cr | ₹511 Cr | ₹438 Cr | ₹1,077 Cr | ₹1,096 Cr | ₹1,322 Cr | ₹1,534 Cr | ₹1,871 Cr |
| Investing | ₹-3,323 Cr | ₹60 Cr | ₹-135 Cr | ₹-514 Cr | ₹-374 Cr | ₹-886 Cr | ₹-779 Cr | ₹-1,538 Cr |
| Financing | ₹4,257 Cr | ₹-862 Cr | ₹-143 Cr | ₹-517 Cr | ₹-471 Cr | ₹-86 Cr | ₹-714 Cr | ₹164 Cr |
| Free Cash Flow | ₹69 Cr | ₹511 Cr | ₹438 Cr | ₹1,077 Cr | ₹1,096 Cr | ₹1,322 Cr | ₹1,534 Cr | ₹1,871 Cr |
Shareholding
Promoter 31.17% Institutions 57.43% Public 11.4%
Efficiency & Working Capital
ROCE3.3%
Interest Coverage5.3
Dividend Payout—
Debtor Days37 d
Inventory Days5 d
Payable Days38 d
Cash Conversion Cycle4 d
Working Capital Days42 d
Shareholding Details
As of 2026-06-30
Promoter31.2%
FII25.2%
DII32.2%
Institutions57.4%
Public11.4%
Promoter Pledge0%
No. of Shareholders2,20,743
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% |
| FIIs | 26.3% | 23.7% | 23.2% | 23.3% | 25.3% | 26.8% | 27.4% | 27.2% | 27.9% | 27.8% | 26% | 25.2% |
| DIIs | 26.5% | 29.3% | 31.2% | 32.3% | 30.7% | 30.1% | 29.5% | 29.8% | 29.1% | 29.3% | 31.4% | 32.2% |
| Public | 16% | 15.8% | 14.4% | 13.2% | 12.8% | 12% | 12% | 11.9% | 11.8% | 11.7% | 11.5% | 11.4% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 1,31,516 | 1,35,664 | 1,57,165 | 1,54,260 | 2,04,184 | 2,21,750 | 2,18,329 | 2,05,373 | 2,20,766 | 2,33,156 | 2,26,685 | 2,20,743 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Northern Tk Venture Pte. Ltd. | Shareholding of Promoter and Promoter Group | 31.2% | 23.53 Cr |
| Hdfc Mutual Fund - Hdfc Pharma And Healthcare Fund | Public Shareholding | 6.5% | 4.93 Cr |
| Kotak Mahindra Trustee Co Ltd A/c Kotak Healthcare | Public Shareholding | 5.8% | 4.35 Cr |
| Rekha Jhunjhunwala | Public Shareholding | 4% | 3.04 Cr |
| Axis Mutual Fund Trustee Ltd. A/c Axis Mutual Fund | Public Shareholding | 2.9% | 2.22 Cr |
| Nippon Life India Trustee Ltd-a/c Nippon India Nif | Public Shareholding | 2.5% | 1.89 Cr |
| Sbi Life Insurance Co. Ltd | Public Shareholding | 1.7% | 1.31 Cr |
| Amansa Holdings Private Limited | Public Shareholding | 1.6% | 1.21 Cr |
| Dsp Nifty Midcap 150 Etf | Public Shareholding | 1.4% | 1.09 Cr |
| Edelweiss Trusteeship Co Ltd Ac- Edelweiss Mf Ac- | Public Shareholding | 1.2% | 93,52,891 |
| Hdfc Life Insurance Company Limited | Public Shareholding | 1.2% | 91,89,065 |
| Axis Bank Limited | Public Shareholding | 1.2% | 90,00,000 |
| Kotak Funds - India Midcap Fund | Public Shareholding | 1.1% | 85,50,000 |
| Jupiter India Fund | Public Shareholding | 1.1% | 85,59,006 |
| Aditya Birla Sun Life Trustee Private Limited A/c | Public Shareholding | 1.1% | 81,94,942 |
| Fidelity Funds - India Focus Fund | Public Shareholding | 1.1% | 79,06,099 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Ashutosh Raghuvanshi | Managing Director & CEO | 2025 |
| DILIP KADAMBI | Non-Exec & Non-Independent Dir | 2025 |
| Indrajit Banerjee | Independent Non Exe. Director | 2025 |
| Shailaja Chandra | Independent Non Exe. Director | 2025 |
| Tomo Nagahiro | Non-Exec & Non-Independent Dir | 2025 |
| Mehmet Ali Aydinlar | Non Executive Director | 2025 |
| Lim Tsin Lin | Non-Exec & Non-Independent Dir | 2025 |
| Ashok Pandit | Non-Exec & Non-Independent Dir | 2025 |
| Prem Kumar Nair | Non-Exec & Non-Independent Dir | 2025 |
| Leo Puri | Chairman & Independent Directo | 2025 |
| Keith Hsiu Chin Lim | Additional Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Healthcare services | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹1,792 Cr | 100% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 850 | 755 | 755 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-24 | Dividend (1/- per share) | Final |
| dividend | 2026-07-24 | ₹1 (10%) | Final |
| dividend | 2025-07-25 | ₹1 (10%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 12,708 | 0 | 0 | 23 | 2 | 12,733 |
| 2025 | 12,164 | 0 | 0 | 0 | 2 | 12,166 |
| 2025 | 365 | 0 | 0 | 23 | 0 | 387 |
Substantial Acquisitions (SAST)
3 disclosure(s)
Market20/12/2024 · 1,51,95,198
Market02/08/2024 · 7,28,188
Market19/03/2024 · 20,15,481
Company Information
Incorporated1996
ChairmanLeo Puri
AuditorB S R & Co LLP
Investor Email[email protected]; contactus@fortis
📍 Fortis Hospital Sector-62, Phase-VIII, Mohali, Punjab, 160062
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search